Global Autoimmune Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Autoimmune Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 93

Published Date: 30 Jul 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Autoimmune Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Autoimmune Therapeutics Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Autoimmune Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Autoimmune Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies

Market segment by Application, can be divided into
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Autoimmune Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Autoimmune Therapeutics Drugs, with revenue, gross margin and global market share of Autoimmune Therapeutics Drugs from 2019 to 2021.
Chapter 3, the Autoimmune Therapeutics Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Autoimmune Therapeutics Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Autoimmune Therapeutics Drugs research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Autoimmune Therapeutics Drugs
1.2 Classification of Autoimmune Therapeutics Drugs by Type
1.2.1 Overview: Global Autoimmune Therapeutics Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Type in 2020
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.2.5 Disease-Modifying Anti-Rheumatic Drugs
1.2.6 Monoclonal Antibodies
1.3 Global Autoimmune Therapeutics Drugs Market by Application
1.3.1 Overview: Global Autoimmune Therapeutics Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Autoimmune Therapeutics Drugs Market Size & Forecast
1.5 Global Autoimmune Therapeutics Drugs Market Size and Forecast by Region
1.5.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Autoimmune Therapeutics Drugs Market Size by Region, (2016-2021)
1.5.3 North America Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Autoimmune Therapeutics Drugs Market Drivers
1.6.2 Autoimmune Therapeutics Drugs Market Restraints
1.6.3 Autoimmune Therapeutics Drugs Trends Analysis

2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Autoimmune Therapeutics Drugs Product and Solutions
2.1.4 AbbVie Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Autoimmune Therapeutics Drugs Product and Solutions
2.2.4 Amgen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Autoimmune Therapeutics Drugs Product and Solutions
2.3.4 Novartis Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Solutions
2.4.4 Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli Lilly and Company Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Autoimmune Therapeutics Drugs Product and Solutions
2.5.4 Pfizer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Roche Holding AG
2.6.1 Roche Holding AG Details
2.6.2 Roche Holding AG Major Business
2.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Product and Solutions
2.6.4 Roche Holding AG Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Holding AG Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Autoimmune Therapeutics Drugs Product and Solutions
2.7.4 AstraZeneca Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Product and Solutions
2.8.4 Abbott Laboratories Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Abbott Laboratories Recent Developments and Future Plans
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business
2.9.3 Genentech Autoimmune Therapeutics Drugs Product and Solutions
2.9.4 Genentech Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genentech Recent Developments and Future Plans
2.10 Merck & Co.
2.10.1 Merck & Co. Details
2.10.2 Merck & Co. Major Business
2.10.3 Merck & Co. Autoimmune Therapeutics Drugs Product and Solutions
2.10.4 Merck & Co. Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Merck & Co. Recent Developments and Future Plans
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business
2.11.3 Bayer Autoimmune Therapeutics Drugs Product and Solutions
2.11.4 Bayer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bayer Recent Developments and Future Plans
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Autoimmune Therapeutics Drugs Product and Solutions
2.12.4 Biogen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Biogen Recent Developments and Future Plans
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business
2.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Solutions
2.13.4 GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 GlaxoSmithKline Recent Developments and Future Plans
2.14 Perrigo
2.14.1 Perrigo Details
2.14.2 Perrigo Major Business
2.14.3 Perrigo Autoimmune Therapeutics Drugs Product and Solutions
2.14.4 Perrigo Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Perrigo Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Autoimmune Therapeutics Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Autoimmune Therapeutics Drugs Players Market Share
3.2.2 Top 10 Autoimmune Therapeutics Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Autoimmune Therapeutics Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Autoimmune Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Autoimmune Therapeutics Drugs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.2 Autoimmune Therapeutics Drugs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
6.2 North America Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
6.3 North America Autoimmune Therapeutics Drugs Market Size by Country
6.3.1 North America Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
6.3.2 United States Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
7.2 Europe Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country
7.3.1 Europe Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
7.3.2 Germany Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.3 France Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region
8.3.1 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2016-2026)
8.3.2 China Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.5 India Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
9.2 South America Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
9.3 South America Autoimmune Therapeutics Drugs Market Size by Country
9.3.1 South America Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country
10.3.1 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Autoimmune Therapeutics Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Autoimmune Therapeutics Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Autoimmune Therapeutics Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region (2021-2026)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Autoimmune Therapeutics Drugs Product and Solutions
Table 9. AbbVie Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Autoimmune Therapeutics Drugs Product and Solutions
Table 13. Amgen Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Autoimmune Therapeutics Drugs Product and Solutions
Table 17. Novartis Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Solutions
Table 21. Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Autoimmune Therapeutics Drugs Product and Solutions
Table 25. Pfizer Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 27. Roche Holding AG Major Business
Table 28. Roche Holding AG Autoimmune Therapeutics Drugs Product and Solutions
Table 29. Roche Holding AG Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Autoimmune Therapeutics Drugs Product and Solutions
Table 33. AstraZeneca Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Abbott Laboratories Major Business
Table 36. Abbott Laboratories Autoimmune Therapeutics Drugs Product and Solutions
Table 37. Abbott Laboratories Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genentech Corporate Information, Head Office, and Major Competitors
Table 39. Genentech Major Business
Table 40. Genentech Autoimmune Therapeutics Drugs Product and Solutions
Table 41. Genentech Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Merck & Co. Corporate Information, Head Office, and Major Competitors
Table 43. Merck & Co. Major Business
Table 44. Merck & Co. Autoimmune Therapeutics Drugs Product and Solutions
Table 45. Merck & Co. Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bayer Corporate Information, Head Office, and Major Competitors
Table 47. Bayer Major Business
Table 48. Bayer Autoimmune Therapeutics Drugs Product and Solutions
Table 49. Bayer Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Biogen Corporate Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Autoimmune Therapeutics Drugs Product and Solutions
Table 53. Biogen Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 55. GlaxoSmithKline Major Business
Table 56. GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Solutions
Table 57. GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Perrigo Corporate Information, Head Office, and Major Competitors
Table 59. Perrigo Major Business
Table 60. Perrigo Autoimmune Therapeutics Drugs Product and Solutions
Table 61. Perrigo Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Players (2019-2021)
Table 63. Global Autoimmune Therapeutics Drugs Revenue Share by Players (2019-2021)
Table 64. Breakdown of Autoimmune Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Autoimmune Therapeutics Drugs Players Head Office, Products and Services Provided
Table 66. Autoimmune Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 67. Autoimmune Therapeutics Drugs New Entrants and Expansion Plans
Table 68. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Type (2016-2021)
Table 69. Global Autoimmune Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 70. Global Autoimmune Therapeutics Drugs Revenue Forecast by Type (2021-2026)
Table 71. Global Autoimmune Therapeutics Drugs Revenue by Application (2016-2021)
Table 72. Global Autoimmune Therapeutics Drugs Revenue Forecast by Application (2021-2026)
Table 73. North America Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Autoimmune Therapeutics Drugs Picture
Figure 2. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type in 2020
Figure 3. NSAIDs
Figure 4. Corticosteroids
Figure 5. Disease-Modifying Anti-Rheumatic Drugs
Figure 6. Monoclonal Antibodies
Figure 7. Autoimmune Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 8. Hospitals and Clinics Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Autoimmune Therapeutics Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Autoimmune Therapeutics Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 14. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 15. North America Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Autoimmune Therapeutics Drugs Market Drivers
Figure 21. Autoimmune Therapeutics Drugs Market Restraints
Figure 22. Autoimmune Therapeutics Drugs Market Trends
Figure 23. AbbVie Recent Developments and Future Plans
Figure 24. Amgen Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Eli Lilly and Company Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Roche Holding AG Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Abbott Laboratories Recent Developments and Future Plans
Figure 31. Genentech Recent Developments and Future Plans
Figure 32. Merck & Co. Recent Developments and Future Plans
Figure 33. Bayer Recent Developments and Future Plans
Figure 34. Biogen Recent Developments and Future Plans
Figure 35. GlaxoSmithKline Recent Developments and Future Plans
Figure 36. Perrigo Recent Developments and Future Plans
Figure 37. Global Autoimmune Therapeutics Drugs Revenue Share by Players in 2020
Figure 38. Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Autoimmune Therapeutics Drugs Revenue Market Share in 2020
Figure 40. Global Top 10 Players Autoimmune Therapeutics Drugs Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Autoimmune Therapeutics Drugs Revenue Share by Type in 2020
Figure 43. Global Autoimmune Therapeutics Drugs Market Share Forecast by Type (2021-2026)
Figure 44. Global Autoimmune Therapeutics Drugs Revenue Share by Application in 2020
Figure 45. Global Autoimmune Therapeutics Drugs Market Share Forecast by Application (2021-2026)
Figure 46. North America Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 47. North America Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 48. North America Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 49. United States Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 53. Europe Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 54. Europe Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 55. Germany Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Autoimmune Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 63. China Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Autoimmune Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Autoimmune Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 93

Published Date: 30 Jul 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Autoimmune Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Autoimmune Therapeutics Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Autoimmune Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Autoimmune Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies

Market segment by Application, can be divided into
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Autoimmune Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Autoimmune Therapeutics Drugs, with revenue, gross margin and global market share of Autoimmune Therapeutics Drugs from 2019 to 2021.
Chapter 3, the Autoimmune Therapeutics Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Autoimmune Therapeutics Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Autoimmune Therapeutics Drugs research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Autoimmune Therapeutics Drugs
1.2 Classification of Autoimmune Therapeutics Drugs by Type
1.2.1 Overview: Global Autoimmune Therapeutics Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Type in 2020
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.2.5 Disease-Modifying Anti-Rheumatic Drugs
1.2.6 Monoclonal Antibodies
1.3 Global Autoimmune Therapeutics Drugs Market by Application
1.3.1 Overview: Global Autoimmune Therapeutics Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Autoimmune Therapeutics Drugs Market Size & Forecast
1.5 Global Autoimmune Therapeutics Drugs Market Size and Forecast by Region
1.5.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Autoimmune Therapeutics Drugs Market Size by Region, (2016-2021)
1.5.3 North America Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Autoimmune Therapeutics Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Autoimmune Therapeutics Drugs Market Drivers
1.6.2 Autoimmune Therapeutics Drugs Market Restraints
1.6.3 Autoimmune Therapeutics Drugs Trends Analysis

2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Autoimmune Therapeutics Drugs Product and Solutions
2.1.4 AbbVie Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Autoimmune Therapeutics Drugs Product and Solutions
2.2.4 Amgen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Autoimmune Therapeutics Drugs Product and Solutions
2.3.4 Novartis Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Solutions
2.4.4 Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eli Lilly and Company Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Autoimmune Therapeutics Drugs Product and Solutions
2.5.4 Pfizer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Roche Holding AG
2.6.1 Roche Holding AG Details
2.6.2 Roche Holding AG Major Business
2.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Product and Solutions
2.6.4 Roche Holding AG Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Holding AG Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Autoimmune Therapeutics Drugs Product and Solutions
2.7.4 AstraZeneca Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Product and Solutions
2.8.4 Abbott Laboratories Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Abbott Laboratories Recent Developments and Future Plans
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business
2.9.3 Genentech Autoimmune Therapeutics Drugs Product and Solutions
2.9.4 Genentech Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genentech Recent Developments and Future Plans
2.10 Merck & Co.
2.10.1 Merck & Co. Details
2.10.2 Merck & Co. Major Business
2.10.3 Merck & Co. Autoimmune Therapeutics Drugs Product and Solutions
2.10.4 Merck & Co. Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Merck & Co. Recent Developments and Future Plans
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business
2.11.3 Bayer Autoimmune Therapeutics Drugs Product and Solutions
2.11.4 Bayer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bayer Recent Developments and Future Plans
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Autoimmune Therapeutics Drugs Product and Solutions
2.12.4 Biogen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Biogen Recent Developments and Future Plans
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business
2.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Solutions
2.13.4 GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 GlaxoSmithKline Recent Developments and Future Plans
2.14 Perrigo
2.14.1 Perrigo Details
2.14.2 Perrigo Major Business
2.14.3 Perrigo Autoimmune Therapeutics Drugs Product and Solutions
2.14.4 Perrigo Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Perrigo Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Autoimmune Therapeutics Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Autoimmune Therapeutics Drugs Players Market Share
3.2.2 Top 10 Autoimmune Therapeutics Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Autoimmune Therapeutics Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Autoimmune Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Autoimmune Therapeutics Drugs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.2 Autoimmune Therapeutics Drugs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
6.2 North America Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
6.3 North America Autoimmune Therapeutics Drugs Market Size by Country
6.3.1 North America Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
6.3.2 United States Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
7.2 Europe Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country
7.3.1 Europe Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
7.3.2 Germany Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.3 France Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region
8.3.1 Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2016-2026)
8.3.2 China Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.5 India Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
9.2 South America Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
9.3 South America Autoimmune Therapeutics Drugs Market Size by Country
9.3.1 South America Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country
10.3.1 Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Autoimmune Therapeutics Drugs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Autoimmune Therapeutics Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Autoimmune Therapeutics Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Autoimmune Therapeutics Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region (2021-2026)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Autoimmune Therapeutics Drugs Product and Solutions
Table 9. AbbVie Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Autoimmune Therapeutics Drugs Product and Solutions
Table 13. Amgen Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Autoimmune Therapeutics Drugs Product and Solutions
Table 17. Novartis Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Solutions
Table 21. Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Autoimmune Therapeutics Drugs Product and Solutions
Table 25. Pfizer Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 27. Roche Holding AG Major Business
Table 28. Roche Holding AG Autoimmune Therapeutics Drugs Product and Solutions
Table 29. Roche Holding AG Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Autoimmune Therapeutics Drugs Product and Solutions
Table 33. AstraZeneca Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Abbott Laboratories Major Business
Table 36. Abbott Laboratories Autoimmune Therapeutics Drugs Product and Solutions
Table 37. Abbott Laboratories Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genentech Corporate Information, Head Office, and Major Competitors
Table 39. Genentech Major Business
Table 40. Genentech Autoimmune Therapeutics Drugs Product and Solutions
Table 41. Genentech Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Merck & Co. Corporate Information, Head Office, and Major Competitors
Table 43. Merck & Co. Major Business
Table 44. Merck & Co. Autoimmune Therapeutics Drugs Product and Solutions
Table 45. Merck & Co. Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bayer Corporate Information, Head Office, and Major Competitors
Table 47. Bayer Major Business
Table 48. Bayer Autoimmune Therapeutics Drugs Product and Solutions
Table 49. Bayer Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Biogen Corporate Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Autoimmune Therapeutics Drugs Product and Solutions
Table 53. Biogen Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 55. GlaxoSmithKline Major Business
Table 56. GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Solutions
Table 57. GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Perrigo Corporate Information, Head Office, and Major Competitors
Table 59. Perrigo Major Business
Table 60. Perrigo Autoimmune Therapeutics Drugs Product and Solutions
Table 61. Perrigo Autoimmune Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Players (2019-2021)
Table 63. Global Autoimmune Therapeutics Drugs Revenue Share by Players (2019-2021)
Table 64. Breakdown of Autoimmune Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Autoimmune Therapeutics Drugs Players Head Office, Products and Services Provided
Table 66. Autoimmune Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 67. Autoimmune Therapeutics Drugs New Entrants and Expansion Plans
Table 68. Global Autoimmune Therapeutics Drugs Revenue (USD Million) by Type (2016-2021)
Table 69. Global Autoimmune Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 70. Global Autoimmune Therapeutics Drugs Revenue Forecast by Type (2021-2026)
Table 71. Global Autoimmune Therapeutics Drugs Revenue by Application (2016-2021)
Table 72. Global Autoimmune Therapeutics Drugs Revenue Forecast by Application (2021-2026)
Table 73. North America Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Autoimmune Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Autoimmune Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Autoimmune Therapeutics Drugs Picture
Figure 2. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type in 2020
Figure 3. NSAIDs
Figure 4. Corticosteroids
Figure 5. Disease-Modifying Anti-Rheumatic Drugs
Figure 6. Monoclonal Antibodies
Figure 7. Autoimmune Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 8. Hospitals and Clinics Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Autoimmune Therapeutics Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Autoimmune Therapeutics Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 14. Global Autoimmune Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 15. North America Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Autoimmune Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Autoimmune Therapeutics Drugs Market Drivers
Figure 21. Autoimmune Therapeutics Drugs Market Restraints
Figure 22. Autoimmune Therapeutics Drugs Market Trends
Figure 23. AbbVie Recent Developments and Future Plans
Figure 24. Amgen Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Eli Lilly and Company Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Roche Holding AG Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Abbott Laboratories Recent Developments and Future Plans
Figure 31. Genentech Recent Developments and Future Plans
Figure 32. Merck & Co. Recent Developments and Future Plans
Figure 33. Bayer Recent Developments and Future Plans
Figure 34. Biogen Recent Developments and Future Plans
Figure 35. GlaxoSmithKline Recent Developments and Future Plans
Figure 36. Perrigo Recent Developments and Future Plans
Figure 37. Global Autoimmune Therapeutics Drugs Revenue Share by Players in 2020
Figure 38. Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Autoimmune Therapeutics Drugs Revenue Market Share in 2020
Figure 40. Global Top 10 Players Autoimmune Therapeutics Drugs Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Autoimmune Therapeutics Drugs Revenue Share by Type in 2020
Figure 43. Global Autoimmune Therapeutics Drugs Market Share Forecast by Type (2021-2026)
Figure 44. Global Autoimmune Therapeutics Drugs Revenue Share by Application in 2020
Figure 45. Global Autoimmune Therapeutics Drugs Market Share Forecast by Application (2021-2026)
Figure 46. North America Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 47. North America Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 48. North America Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 49. United States Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 53. Europe Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 54. Europe Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 55. Germany Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Autoimmune Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 63. China Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Autoimmune Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Autoimmune Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Autoimmune Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Autoimmune Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now